|
It's not difficult to give yourself an injection....I beg to differ, particularly when you are delusional, spaced out, weak, and uncoordinated during a reaction. Even an EpiPen becomes challenging to use. Allerject was the best because it gave you audio instructions, but still hard to coordinate in a reaction. (I have had the unfortunate experience of using both types of autoinjector on myself in a reaction.) I would never choose the phial and syringe route if an autoinjector was available, regardless of cost.
A thought: I've heard that here in NZ, some people who need to carry epi ask the doc for a script for a vial of epi and a couple of syringes as it is SO much cheaper. Obviously it wouldn't work for kids but why not for adults? It's not difficult to give yourself an injection....
Thanks everyone, especially spacecanada! Not sure what we will do, but thankfully we have options now. I found that even with the wellscript card AND the epi coupon, it was still $434 ... way too expensive ... especially when we have to buy 2 sets. I also found a Canadian pharmacy online (Canadianpharmacymeds.com) and was wondering if anyone has had any experience with this? I asked and they said it is not generic epi ... that it is epipen brand! I have been paying out of pocket for years (we have a whole closet of expired pens, as we have been buying them for the last 8 years and have only used one, knock wood) and it has always been unreasonable. I wish I had looked into alternatives sooner. However, now it is not just unreasonable, it is unacceptable!
It is picking up steam! Bernie has spotted about it on FB and so has my senator, Amy Klobuchar. I love her so much.
Friends who do not deal with a life threatening allergy are posting about this on FB.
Wow.
Mylan CEO Heather Bresch's total compensation went from $2,453,456 to $18,931,068, a 671 percent increase.
Oh.my.god.
If Mylan loses too much value, it could struggle to defend itself from a future hostile takeover. But Bresch herself is well-insured: According to a recent analysis from Bloomberg, if she’s deposed in a merger, she’s in line for a $61.5 million golden parachute.
Hey Erik! :bye:
Nurses and pharmacists (here, anyway) can train patients on how to use a syringe to administer medications. The only problem is that drawing a syringe during a reaction takes precision and fine motor skills, two things people having a reaction may not have by that point. Cheap, yes. Excellent option for first responder professionals, yes. Suitable for parents and caregivers of those with allergies, possibly. Suitable for self-injection, unlikely.
[url]http://www.fox4news.com/business/196851503-story[/url]
Mylan to make a generic epi pen...hmmm?
I wonder if it would be possible (for sure it would be cost-effective in the long run) to order a vial of epi and make your own ana-kit type setup except with an autoinjector. Something like this:
[url]http://www.unilife.com/product-platforms/auto-injectors/lisa-auto-injector[/url]
I wonder if it would be possible (for sure it would be cost-effective in the long run) to order a vial of epi and make your own ana-kit type setup except with an autoinjector.
The problem with this--- and this is the precise problem with vials of epinephrine-- is that epinephrine is stable for literally only a few HOURS when drawn into a syringe under exposure to air.
WOW!
[url]http://www.huffingtonpost.com/entry/father-to-epipen-ceo-my-daughters-will-be-nothing_us_57c48b04e4b024fca58c9367?[/url]
In the interest of public access to critical information here is a partial link to Mylan's citizen petition to block a generic from market. Their arguement goes something like, "Schools are trained to use branded EpiPens so this generic will dangerous because it's slightly different to use."
[url]http://pharmamedtechbi.com/~/media/Supporting%20Documents/The%20Pink%20Sheet%20DAILY/2015/January/Citizen_Petition_Mylan_Specialty_epinephrine%20autoinjector%20ANDA.pdf[/url]
Sen. Amy Klobuchar, D-Minnesota, last month called for a Federal Trade Commission investigation into whether Mylan engaged in any anti-competitive acts connected with the series of price increases that have brought attention to the EpiPen. In a letter to the FTC, she said the commission “should investigate whether Mylan Pharmaceuticals engaged in activity, such as using incentives or exclusionary contracts with insurers, distributors or pharmacies, to deny an alternative product access to the market.”
An FTC spokeswoman said in August it would “carefully consider” Klobuchar’s letter. A spokesman said Tuesday the FTC could not comment on investigations by other agencies, nor on whether the FTC is conducting an investigation. Klobuchar, along with Sen. Richard Blumenthal, D-Connecticut, continued to pressure the FTC on Tuesday, urging the commission to issue a subpoena to Mylan to determine how the company gained its “monopoly position.”
In the U.S. alone, Mylan sells 21 billion doses annually of 635 products,
at an average selling price of approximately $0.25 per dose across all of our specialty and generic
products, including the EpiPen Auto-Injector.
I saw that, but was also concerned that they were handing out pb sandwiches to every single person there. Hope no one was severely allergic. I was watching to see if anyone was making a run for the doors!
I don't like where this whole 'preventative drug' thing is headed. That's just UGLY.
Could there ever be some sort of fallout from this making EpiPens themselves being pulled from the market in America (if, say, Mylan's rights to produce it are revoked)? Or tarnishing the brand for us in other countries that have no other option? EpiPen here is made by another company, yes, but could this ugly investigation somehow affect the EpiPen brand elsewhere? (Because it kind of makes me nervous. There are no generics or alternatives here. At all.)
And...the CEOs mother was involved with getting Epipens in schools.
.usatoday.com/story/news/politics/2016/09/20/family-matters-epipens-had-help-getting-schools-manchin-bresch/90435218/
Under the auspices of a leadership position at the NSBA. Again, nothing we here did not call it for what it was years ago. I know someone queried if this awareness existed on other forums, and what I'm guessing is some sort of (legitimate) cursory evaluation of critique vs. obeisance based on Mylan funding.
I would guess not, but not based on financial influence. Interwebz, please forgive what will undoubtedly sound like conceit or hubris, but given the professional array here I would not expect many other such watering holes of SOAK + scholarship + communication/relationships capable of producing the required analysis. And if you think about this for the long term crew we only accrue more education and experience.
I don't like where this whole 'preventative drug' thing is headed. That's just UGLY.
Could there ever be some sort of fallout from this making EpiPens themselves being pulled from the market in America (if, say, Mylan's rights to produce it are revoked)? Or tarnishing the brand for us in other countries that have no other option? EpiPen here is made by another company, yes, but could this ugly investigation somehow affect the EpiPen brand elsewhere? (Because it kind of makes me nervous. There are no generics or alternatives here. At all.)
There are plenty of fingerprints all over the fabrication of this monopoly. Mylan alone is not solely responsible: to ignore that critical component to market manipulation invites the same collusion in the future. The blame needs to be portioned out accordingly.
Bresch had mommy and daddy in government and the NSBA. Mylan funds every last allergy nonprofit out there in "patient education partnerships" with celeb spokespersons. The FDA actually entertained a so-called citizen's petition from Mylan to block Teva's generic entry into the market.
The ugly fact is influence eased the path to total market control. Greed is but one ingredient, and I am fearful of a short-memory public that will overlook the supporting cast scuttling away that facilitated serving us up on a platter to Mylan.
Until resigning to become Chief Medical Officer of Aimmune, Dr. Adelman was a member of the prestigious Research Advisory Board of Food Allergy Research & Education (FARE), the world’s largest private funder of food allergy research. For several years, he was actively involved in reviewing FARE’s research funding and helped to shape the organization’s overall research strategy.
“We’re deeply grateful for the contributions Dan has made as a member of our Research Advisory Board, and we’re pleased to see him join Aimmune,” said James R. Baker, Jr., M.D., FARE CEO and Chief Medical Officer. “Dan’s leadership and clinical expertise will be great assets as Aimmune continues to progress toward what would be the first FDA-approved oral immunotherapy for food allergies. This treatment could make a great impact on the lives of millions of people at risk from peanut allergy.”
As Ciel did, I am reporting the cost of my EpiPen refill in BC, Canada: $0 with third party medical insurance. (It is a VERY good policy. No fee except for brand name drugs.)
Without insurance coverage, it would have been $102.64 with a prescription or $95.65 over the counter (no $6.99 dispensing fee.) This was about the same price I paid for a refill in March in Alberta.
My expiration date was January 2017, however, which made me a little upset (4 months, seriously?) but with no cost refills it doesn't really matter to me one way or the other.
When purchased OTC, isn't tax added? There was something my doctor prescribed many years ago, and it was cheaper as a prescription because the tax was higher than the dispensing fee.Possibly. I am not sure which taxes would apply: 5% GST would be cheaper than the dispensing fee, but if you had to add the 7% PST (in BC) on top of that (making 12% total tax) the prescription would be cheaper... Still cheaper than in America though.
Allergic Living re: return of AuviQ
[url]http://allergicliving.com/2016/10/26/auvi-q-makers-announce-relaunch-of-talking-auto-injector/[/url]
The reason I was asking, there is a post on Facebook that people are sharing regarding generic epipens. I did point out the info is American (being shared by Canadians). But I also thought the price was inaccurate. It says it costs under $10.